
Keyan Biotech's "Fasili Light Sensitive Subdermal Filler" was approved by China's National Medical Products Administration and became the first lidocaine-containing hyaluronic acid subcutaneous implant certificate in Taiwan.
AI-generated summary
Keyan Biotechnology is a major hyaluronic acid manufacturer in China. The certified product has gone through a 7-year research and development and review process.
Keyan Chairman Han Kaicheng (left) and General Manager Han Taixian (right). (File photo)
Keyan Biotechnology (1786), a major domestic biotech and medical hyaluronic acid manufacturer, announced today that its latest third-generation dual cross-linked technology product "Fasili Light Sensitive Subdermal Filler (containing lidocaine cross-linked sodium hyaluronate gel for injection)" has officially passed the approval of the China National Medical Products Administration (NMPA) and successfully obtained the third-class medical device registration certificate.
Keyan said that this is Taiwan's first certificate for "medicated (lidocaine) hyaluronic acid subcutaneous implant" approved for marketing in China, symbolizing that Keyan Biotechnology has entered a new milestone in its strategic layout in the cross-strait micro-plastic surgery market, and will fully seize China's hundreds of billions of compliant medical and aesthetic consumption business opportunities.
Keyan pointed out that the evidence collection of "Fasili Light Sensation (containing lidocaine)" is extremely valuable. Since 2020, this product has undergone multiple strict official quality inspections and three years of rigorous clinical trials. After being officially delivered in 2023, it once again passed a four-year strict review and replacement process. It took more than 7 years to fully prove that Keyan's products have the highest standards in safety, effectiveness and production, and successfully broke through the difficult entry threshold of China's compliant medical beauty market.
According to reports from industry research institutions, it is estimated that the number of injections in China's injectable medical aesthetics market will exceed 10 million in 2026, and its economic scale will reach more than 200 billion yuan, of which hyaluronic acid subcutaneous fillers will contribute the main momentum.

Delta Electronics announced its third-quarter financial report, with a single-quarter net profit of 23.495 billion yuan and earnings per share of 9.04 yuan. Despite the expansion of revenue, gross profit margin fell to 34.08%. The market will pay attention to the relevant explanations about the AI data center layout, changes in gross profit margin and the US ITC 337 investigation in tomorrow's legal meeting.

China officially announced that its GDP growth rate in the first three quarters of this year was 4.6%. However, due to the sluggish housing market and weak consumption, the accuracy of the data has been questioned. Analysts pointed out that the transparency of China's economic data has declined, and the gap between official data and independent agency estimates has widened, indicating Beijing's increasing political sensitivity to economic difficulties.

Henan's first "Trans-Baltic Sea China-Europe Train" departed from Zhengzhou on October 28. The line exits through Manzhouli, passes through St. Petersburg, Russia, Rotterdam, the Netherlands, and finally reaches Duisburg, Germany, through the "rail-sea combined transport" model, aiming to improve the flexibility and resilience of the Asia-Europe supply chain.

The Industrial Development Administration of the Ministry of Economic Affairs is assisting Taiwan's fastener industry in their transformation through AI coaching, R&D subsidies and financial support. At present, it has guided 209 companies to introduce AI and assisted them to secure nearly US$150 million in business opportunities, successfully entering high value-added markets such as semiconductor equipment, electric vehicles and drones, and getting rid of traditional price competition.

In the fourth quarter, cross-border e-commerce entered its peak season, and the export of consumer electronics and AI hardware overseas grew significantly. In the face of rising sea freight and tight shipping space, companies have ensured that goods can be shipped to sea efficiently through the innovation of the "check first, then load" model and improve port efficiency. Exports have maintained steady growth in the first three quarters.
Chinese brands are gaining recognition in overseas photography, running shoes and consumer goods through high-quality products, quick responses to market feedback and innovative designs. Experts pointed out that this is not only an improvement in product strength, but also a new attempt by Chinese brands in meaning identification and cultural expression.